Publications by authors named "Samuel Funt"

Claim this Profile
O
Optimizing the Approach to Surgical Decision-Making in Patients With Pure Seminoma Metastatic to the Retroperitoneum.
Richard S Matulewicz, Darren R Feldman, Joel Sheinfeld, Samuel A Funt

J Urol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can Novel Biomarkers Augment Traditional Surveillance Paradigms in Early-stage Testicular Germ Cell Tumors? A Case Study in Pre-clinical Relapse Detection Using a Combination Micro-RNA-371a-3p and 372-3p Assay.
Jonathan Huynh, Adam Levin, Vincent D'Andrea, Brandon Williams, Andrea Knezevic, Samuel A Funt

Urology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance Characteristics of an Analytic Model Predicting Retroperitoneal Lymph Node Dissection Pathology Following First-Line Chemotherapy for Patients With Metastatic Nonseminomatous Germ Cell Tumors.
Richard S Matulewicz, Melissa Assel, Andrew J Vickers, Viranda H Jayalath, Samuel A Gold, Samuel A Funt

J Urol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline health-related quality-of-life metrics among patients with testicular germ cell tumours.
Samuel A Gold, Rebecca Yu, Viranda H Jayalath, Fady Baky, Nicole Liso, Samuel A Funt

BJU Int· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the Testicular Health Outcomes Report (THOR): a testicular cancer health-related quality of life instrument.
Samuel A Gold, Amy L Tin, Viranda H Jayalath, Fady Baky, Nicole Liso, Samuel A Funt

BJU Int· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathologic and Oncologic Outcomes of Patients Undergoing Orchiectomy After Chemotherapy for Advanced Testicular Germ Cell Tumors.
Viranda H Jayalath, Fady Baky, Samuel A Gold, Nicole Liso, Brandon Williams, Samuel A Funt

Eur Urol Open Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of Informed Consent via Telemedicine Compared With In-Person for Clinical Cancer Research.
Michal Sternschuss, Michael Lattanzi, Emily Vertosick, Mia Austria, Sené Martin, Samuel A Funt

JCO Oncol Pract· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of serum and plasma microRNA expression levels in patients with germ cell tumours.
Fady Baky, Richard S Matulewicz, Andrea Knezevic, Jahwa Hossain, Brandon Williams, Samuel A Funt

BJU Int· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease.
Jack P Gleeson, Andrea Knezevic, Maria Bromberg, Sujata Patil, Joel Sheinfeld, Samuel A Funt

J Clin Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Clinical Outcomes of Patients With Negative Pathology (pN0) at Primary Retroperitoneal Lymph Node Dissection.
Fady Baky, Nicole Liso, Brandon Williams, Andrea Knezevic, Samuel A Funt

Clin Genitourin Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Outcomes of Regressed or "Burnt Out" Primary Testicular Germ Cell Tumors.
Fady J Baky, Nicole Liso, Brandon Williams, Victor E Reuter, Satish K Tickoo, Samuel A Funt

Urology· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene and Protein Expression of MAGE and Associated Immune Landscape Elements in Non-Small-Cell Lung Carcinoma and Urothelial Carcinomas.
Izak Faiena, Sabina Adhikary, Colleen Schweitzer, Stephanie H Astrow, Tristan Grogan, Samuel A Funt

J Immunother· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative Serum MicroRNA 371a-3p and 372-3p Levels in Patients with Clinically Localized Testicular Masses.
Richard S Matulewicz, Fady Baky, Andrea Knezevic, Joel Sheinfeld, Brandon M Williams, Samuel A Funt

Eur Urol Open Sci· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extramammary Paget disease. Part II. Evidence-based approach to management.
Rohan R Shah, Kalee Shah, Britney N Wilson, Mario M Leitao, Jan Smogorzewski, Samuel A Funt

J Am Acad Dermatol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease.
Jack P Gleeson, Andrea Knezevic, Maria Bromberg, Sujata Patil, Joel Sheinfeld, Samuel A Funt

J Clin Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IMPROVE: a feature model to predict neoepitope immunogenicity through broad-scale validation of T-cell recognition.
Annie Borch, Ibel Carri, Birkir Reynisson, Heli M Garcia Alvarez, Kamilla K Munk, Samuel A Funt

Front Immunol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder Cancer.
Andrew T Lenis, Karissa Whiting, Vignesh Ravichandran, Jacob E Tallman, Syed M Alam, Samuel Funt

JCO Precis Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Retroperitoneal Lymph Node Dissection for Seminoma Metastatic to the Retroperitoneum.
Richard S Matulewicz, Nicole Benfante, Samuel A Funt, Darren R Feldman, Brett Carver

J Urol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ototoxicity associated with high-dose carboplatin for patients with previously treated germ cell tumors.
Samuel A Funt, Andrea Knezevic, Kaamilah Wilson, Maria Bromberg, Amy Budnick

Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of peripheral blood- and tissue-based biomarkers of response to immune checkpoint blockade in urothelial carcinoma.
Rami S Vanguri, James W Smithy, Yanyun Li, Mingqiang Zhuang, Colleen A Maher, Samuel A Funt

J Pathol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience.
Brendan J Guercio, Michal Sarfaty, Min Yuen Teo, Neha Ratna, Cihan Duzgol, Samuel A Funt

Clin Cancer Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Goal-Focused Emotion-Regulation Therapy (GET) in Young Adult Testicular Cancer Survivors: A Randomized Pilot Study.
Michael A Hoyt, Ashley Wei-Ting Wang, Raymond Carrillo Ceja, Jennifer S Cheavens, Michael A Daneshvar, Samuel A Funt

Ann Behav Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy.
Siri Amanda Tvingsholm, Marcus Svensson Frej, Vibeke Mindahl Rafa, Ulla Kring Hansen, Maria Ormhøj, Samuel A Funt

J Immunother Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Genetic Subtypes of Urothelial Carcinoma With Differential Outcomes on Immune Checkpoint Blockade.
Michal Sarfaty, Mahdi Golkaram, Samuel A Funt, Hikmat Al-Ahmadie, Shannon Kaplan

J Clin Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoepitope load, T cell signatures and PD-L2 as combined biomarker strategy for response to checkpoint inhibition immunotherapy.
Annie Borch, Anne-Mette Bjerregaard, Vinicius Araujo Barbosa de Lima, Olga Østrup, Christina Westmose Yde, Samuel A Funt

Front Genet· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis